CompletedEUCTR 2008-001371-30

Anxiolytic effects of single-dose quetiapine XR administration on clinical symptoms and amygdala activation during exposure in patients with simple phobia

This historical record does not confirm current site availability.

Historical research recordGermanyMental health

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Germany
Study phase: Phase 2

Get this study by email

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: Not clearly listed
Sponsor: Universitätsklinikum Münster
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: Germany
Age range: Not clearly listed
Official registry ID: EUCTR 2008-001371-30
Official title: Show the full official title
Anxiolytic effects of single-dose quetiapine XR administration on clinical symptoms and amygdala activation during exposure in patients with simple phobia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Germany

Registry details

Historical country statuses

Germany — Completed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Universitätsklinikum Münster.

Want to explore more studies?

Explore studies